6-hydroxydopamine-induced PC12 cell death is mediated by MEF2D down-regulation

Neurochemical Research

Volumn 36, Issue 2, 2011, Pages 223-231

  Kim, Min Kyoung ^a   Kim, Sang Cheol ^a   Kang, Jung Il ^a   Hyun, Jae Hee ^a   Boo, Hye Jin ^a   Eun, Su Yong ^a   Park, Deok Bae ^a   Yoo, Eun Sook ^a   Kang, Hee Kyoung ^a   Kang, Ji Hoon ^b  

^a Jeju National University School of Medicine   (South Korea)

^b NONE

Author keywords

6 OHDA; cdk5; MAP kinase; MEF2D; NO; PC12 cells

Indexed keywords

CYCLIN DEPENDENT KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2D; NITRIC OXIDE; OXIDOPAMINE; PROTEIN KINASE B; ROSCOVITINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; RAT;

ANIMALS; APOPTOSIS; CYCLIN-DEPENDENT KINASE 5; DNA FRAGMENTATION; DOWN-REGULATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MYOGENIC REGULATORY FACTORS; NITRIC OXIDE; OXIDOPAMINE; PC12 CELLS; PROTEIN KINASE INHIBITORS; PURINES; RATS; SIGNAL TRANSDUCTION;

EID: 78751639833     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0309-x     Document Type: Article

References (49)

1. GE Lyons BK Micales J Schwarz, et al. 1995 Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation J Neurosci 15 5727 5738 1:CAS:528:DyaK2MXnsVOrt7w%3D 7643214
2. TA McKinsey CL Zhang EN Olson 2002 MEF2: a calcium-dependent regulator of cell division, differentiation and death Trends Biochem Sci 27 40 47 1:CAS:528:DC%2BD38XktVOmug%3D%3D 10.1016/S0968-0004(01)02031-X 11796223 (Pubitemid 34131624)
3. AK Shalizi A Bonni 2005 Brawn for brains: the role of MEF2 proteins in the developing nervous system Curr Top Dev Biol 69 239 266 1:CAS:528: DC%2BD2sXmtFKls7k%3D 10.1016/S0070-2153(05)69009-6 16243602 (Pubitemid 43588872)
4. BL Black EN Olson 1998 Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins Annu Rev Cell Dev Biol 14 167 196 1:CAS:528:DyaK1cXnvFyju7o%3D 10.1146/annurev.cellbio.14.1.167 9891782 (Pubitemid 29001453)
5. Z Mao A Bonni F Xia, et al. 1999 Neuronal activity-dependent cell survival mediated by transcription factor MEF2 Science 286 785 790 1:CAS:528:DyaK1MXntFWqu7k%3D 10.1126/science.286.5440.785 10531066 (Pubitemid 29505892)
6. Z Mao M Wiedmann 1999 Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons J Biol Chem 274 31102 31107 1:CAS:528:DyaK1MXntVSls78%3D 10.1074/jbc.274.43.31102 10521511 (Pubitemid 29503955)
7. S Okamoto D Krainc K Sherman, et al. 2000 Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation Proc Natl Acad Sci USA 97 7561 7566 1:CAS:528:DC%2BD3cXksVKhsLs%3D 10.1073/pnas.130502697 10852968 (Pubitemid 30431503)
8. M Li DA Linseman MP Allen, et al. 2001 Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons J Neurosci 21 6544 6552 1:CAS:528: DC%2BD3MXmt1Wjuro%3D 11517243
9. X Gong X Tang M Wiedmann, et al. 2003 Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis Neuron 38 33 46 1:CAS:528:DC%2BD3sXjt1Gmsbs%3D 10.1016/S0896-6273(03) 00191-0 12691662 (Pubitemid 36423351)
10. L Liu JE Cavanaugh Y Wang, et al. 2003 ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons Proc Natl Acad Sci USA 100 8532 8537 1:CAS:528:DC%2BD3sXlsFGnurs%3D 10.1073/pnas.1332804100 12826611 (Pubitemid 36842579)
11. B Gaudilliere Y Shi A Bonni 2002 RNA interference reveals a requirement for myocyte enhancer factor 2A in activity-dependent neuronal survival J Biol Chem 277 46442 46446 1:CAS:528:DC%2BD38XovFKhtb4%3D 10.1074/jbc.M206653200 12235147 (Pubitemid 35417639)
12. DA Linseman CM Bartley SS Le, et al. 2003 Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca (2 +)/calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival J Biol Chem 278 41472 41481 1:CAS:528: DC%2BD3sXotFWnsrk%3D 10.1074/jbc.M307245200 12896970 (Pubitemid 37280976)
13. SW Flavell CW Cowan TK Kim, et al. 2006 Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number Science 311 1008 1012 1:CAS:528:DC%2BD28XhsFSms7s%3D 10.1126/science.1122511 16484497 (Pubitemid 43271729)
14. A Shalizi B Gaudillière Z Yuan, et al. 2006 A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation Science 311 1012 1017 1:CAS:528:DC%2BD28XhsFSms7k%3D 10.1126/science.1122513 16484498 (Pubitemid 43271730)
15. A Shalizi PM Bilimoria J Stegmüller, et al. 2007 PIASx is a MEF2 SUMO E3 ligase that promotes postsynaptic dendritic morphogenesis J Neurosci 27 10037 10046 1:CAS:528:DC%2BD2sXhtVyksbnJ 10.1523/JNEUROSCI.0361-07.2007 17855618 (Pubitemid 47404001)
16. X Tang X Wang X Gong, et al. 2005 Cyclin-Dependent Kinase 5 Mediates Neurotoxin-Induced Degradation of the Transcription Factor Myocyte Enhancer Factor 2 J Neurosci 25 4823 4834 1:CAS:528:DC%2BD2MXksFaltLg%3D 10.1523/JNEUROSCI.1331-05.2005 15888658 (Pubitemid 40664130)
17. PD Smith MP Mount R Shree, et al. 2006 Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2 J Neurosci 26 440 447 1:CAS:528:DC%2BD28XosFWktA%3D%3D 10.1523/JNEUROSCI.2875-05.2006 16407541 (Pubitemid 43237108)
18. Y Saito K Nishio Y Ogawa, et al. 2007 Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action Free Radic Biol Med 42 675 685 1:CAS:528:DC%2BD2sXhs1Smu7o%3D 10.1016/j.freeradbiomed.2006.12.004 17291991 (Pubitemid 46205147)
19. DW Nicholson A Ali NA Thornberry, et al. 1995 Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 376 37 43 1:CAS:528:DyaK2MXmvVGqu7k%3D 10.1038/376037a0 7596430
20. S Singh S Kumar M Dikshit 2010 Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide Redox Rep 15 115 122 1:CAS:528:DC%2BC3cXhtlyqu7nE 20594414
21. G Cohen RE Heikkila 1974 The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents J Biol Chem 249 2447 2452 1:CAS:528:DyaE2cXltVShtbg%3D 4362682
22. X Liu T Shibata S Hisaka T Osawa 2009 Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism Brain Res 1254 18 27 1:CAS:528:DC%2BD1MXhtVens7k%3D 10.1016/j.brainres.2008.11.076 19101523
23. J Bové D Prou C Perier, et al. 2005 Toxin-induced models of Parkinson's disease NeuroRx 2 484 494 10.1602/neurorx.2.3.484 16389312 (Pubitemid 41444882)
24. D Blum S Torch N Lambeng, et al. 2001 Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog Neurobiol 65 135 172 1:CAS:528:DC%2BD3MXkt1Kitbo%3D 10.1016/S0301-0082(01)00003-X 11403877 (Pubitemid 32524182)
25. M Gerlach P Riederer 1996 Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man J neural Trans 103 987 1041 1:CAS:528:DyaK28XntVKku7Y%3D 10.1007/BF01291788 (Pubitemid 26383833)
26. H Sauer WH Oertel 1994 Progressive degeneration of nigrostriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 401 415 1:CAS:528: DyaK2cXisVWktL4%3D 10.1016/0306-4522(94)90605-X 7516500 (Pubitemid 24098798)
27. R Heikkila G Cohen 1971 Inhibition of biogenic amine uptake by hydrogen peroxide: a mechanism for toxic effects of 6-hydroxydopamine Science 172 1257 1258 1:CAS:528:DyaE3MXltVOks7k%3D 10.1126/science.172.3989.1257 5576164
28. AS Permual WK Tordzro M Katz, et al. 1989 Regional effects of 6-hydroxydopamine on free radical scavengers in the rat brain Brain Res 504 139 141 10.1016/0006-8993(89)91611-9 (Pubitemid 20014053)
29. AS Permual VB Gopal WK Tordzro, et al. 1992 Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain Brain Res Bull 29 699 701 10.1016/0361-9230(92)90142-K
30. R Kumar ML Agarwal PK Seth 1995 Free radical-generated neurotoxicity of 6-hydroxydopamine J Neurochem 64 1703 1707 1:CAS:528:DyaK2MXksVKit74%3D 10.1046/j.1471-4159.1995.64041703.x 7891098
31. E Tiffany-Castiglioni RP Saneto PH Proctor, et al. 1982 Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line Biochem Pharmacol 31 181 188 1:CAS:528:DyaL38XhvFOgsr0%3D 10.1016/0006-2952(82)90208-8 7059360
32. DE Decker JS Althaus SE Buxser, et al. 1993 Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine Res Commun Chem Pathol Pharmacol 79 195 208 1:CAS:528:DyaK3sXitVGktb4%3D 8451541
33. 2 in chromaffin cells Eur J Pharmacol 293 55 64 1:CAS:528:DyaK2MXlvFKnsLw%3D 10.1016/0014-2999(95)90114-0 7672008
34. +-induced dopaminergic cell death: role of caspases, ROS and JNK J Neurosci Res 57 86 94 1:CAS:528:DyaK1MXktFCht7s%3D 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E 10397638 (Pubitemid 29293582)
35. J Lotharius LL Dugan KL O'Malley 1999 Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons J Neurosci 19 1284 1293 1:CAS:528:DyaK1MXhtFOhsrw%3D 9952406
36. P Sharma A Veeranna P Sharma M Sharma, et al. 2002 Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway J Biol Chem 277 528 534 1:CAS:528:DC%2BD38XjslGnsg%3D%3D 10.1074/jbc.M109324200 11684694 (Pubitemid 34952088)
37. T Harada T Morooka S Ogawa, et al. 2001 ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1 Nat Cell Biol 3 453 459 1:CAS:528:DC%2BD3MXjsFCksr8%3D 10.1038/35074516 11331872 (Pubitemid 32422080)
38. N Takai H Nakanishi K Tanabe, et al. 1998 Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine J Neurosci Res 54 214 222 1:CAS:528: DyaK1cXmsFCnt78%3D 10.1002/(SICI)1097-4547(19981015)54:2<214::AID-JNR9>3. 0.CO;2-H 9788280 (Pubitemid 28469062)
39. YL Zheng BS Li J Kanungo, et al. 2006 Cdk5 modulation of mitogen-activated protein kinase signaling regulates neuronal survival Mol Biol Cell 18 404 413 10.1091/mbc.E06-09-0851 17108320
40. BS Li L Zhang S Takahashi, et al. 2002 Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3 EMBO J 21 324 333 1:CAS:528:DC%2BD38XhsVSnsrY%3D 10.1093/emboj/21.3.324 11823425 (Pubitemid 34137294)
41. M Nikolic MM Chou W Lu, et al. 1998 The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity Nature 395 194 198 1:CAS:528:DyaK1cXmtVCjtL0%3D 10.1038/26034 9744280 (Pubitemid 28425661)
42. KT Shetty A Veeranna M Takahashi, et al. 2000 Cdk5 and MAPK are associated with complexes of cytoskeletal proteins in rat brain Brain Res Mol Brain Res 76 229 236 10762698
43. A Brunet SR Datta ME Greenberg 2001 Transcription-dependent and -independent control of neuronal survival by the PI3 K-Akt signaling pathway Curr Opin Neurobiol 11 297 305 1:CAS:528:DC%2BD3MXks1Oktbw%3D 10.1016/S0959-4388(00)00211-7 11399427 (Pubitemid 32524094)
44. ZZ Chong F Li K Maiese 2005 Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury Histol Histopathol 20 299 315 1:CAS:528:DC%2BD2MXmsFGrtA%3D%3D 15578447
45. SM Kulich C Horbinski M Patel, et al. 2007 6-Hydroxydopamine induces mitochondrial ERK activation Free Radic Biol Med 43 372 383 1:CAS:528: DC%2BD2sXntFaqsrk%3D 10.1016/j.freeradbiomed.2007.04.028 17602953 (Pubitemid 46977632)
46. Z Jiang PH Yu 2005 Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes Neuroscience 133 405 411 1:CAS:528: DC%2BD2MXks1Gns7Y%3D 10.1016/j.neuroscience.2005.02.028 15878643 (Pubitemid 40726208)
47. PD Smith MJ O'Hare DS Park 2004 Emerging pathogenic role for cyclin dependent kinases in neurodegeneration Cell Cycle 3 289 291 1:CAS:528: DC%2BD2cXltFKrtrg%3D 14726693
48. S Subramaniam K Unsicker 2006 Extracellular signal-regulated kinase as an inducer of non-apoptotic neuronal death Neuroscience 138 1055 1065 1:CAS:528:DC%2BD28Xit1Oit78%3D 10.1016/j.neuroscience.2005.12.013 16442236 (Pubitemid 43363524)
49. K Sako S Fukuhara T Minami, et al. 2008 Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT- dependent activation of myocyte enhancer factor 2 J Biol Chem 284 5592 5601 10.1074/jbc.M806928200 19106103